Figure 3From: The association of blood angioregulatory microRNA levels with circulating endothelial cells and angiogenic proteins in patients receiving dacarbazine and interferonLevels of miR-16, 106a, 126, and 199a of patients administered sequential dacarbazine and interferon-alfa-2b prior to starting treatment (W1), at weeks (W) 9, 17, 25, 33, and at 6 months (M6) after completing treatments. Data represent means ± SEM; n = 12. * = P <0.05 compared to W1.Back to article page